The estimated Net Worth of Viii Associates, L.P.Domain... is at least $923 dollars as of 18 August 2014. Viii Domain owns over 502 units of Otonomy Inc stock worth over $923 and over the last 10 years Viii sold OTIC stock worth over $0.
Viii has made over 1 trades of the Otonomy Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Viii exercised 502 units of OTIC stock worth $4,413 on 18 August 2014.
The largest trade Viii's ever made was exercising 502 units of Otonomy Inc stock on 18 August 2014 worth over $4,413. On average, Viii trades about 502 units every 0 days since 2014. As of 18 August 2014 Viii still owns at least 11,992 units of Otonomy Inc stock.
You can see the complete history of Viii Domain stock trades at the bottom of the page.
Over the last 10 years, insiders at Otonomy Inc have traded over $30,282,796 worth of Otonomy Inc stock and bought 755,065 units worth $12,114,945 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Holdings A/S Novo és Brian H Dovey. On average, Otonomy Inc executives and independent directors trade stock every 66 days with the average trade being worth of $7,317. The most recent stock trade was executed by Vickie L Capps on 28 November 2022, trading 42,242 units of OTIC stock currently worth $4,224.
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus.
Otonomy Inc executives and other stock owners filed with the SEC include: